Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Eli Lilly has outpaced Ozempic-maker Novo Nordisk in the race to develop new incretin drugs.The company is set to capture 50% ...

The current period is critical for public health. Former US Food and Drug Administration (FDA) Commissioner David A. Kessler has called it a “public health disaster.” This issue stems primarily from ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Dr. David Kessler, who led the FDA and later ran Operation Warp Speed, said obesity rates have jumped from 13% in the 1960s ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Amy Spencer, a Missouri resident, navigates the gray market for obesity medications. Despite FDA regulations, she ...

Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...

The first trial of a new monthly weight loss jab has shown jaw-dropping results compared to Wegovy and Mounjaro.

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...